Skip to content

Clinical trials

Hypertension, Pulmonary trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Latvia Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AllRock Bio, Inc.1
Liquidia Technologies, Inc.1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Pulmovant, Inc.1
Regeneron Pharmaceuticals1
Tectonic Therapeutic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary6
Lung Diseases, Interstitial3
Pulmonary Arterial Hypertension3
Cardiovascular Diseases1
Fibrosis1
Hereditary Sensory and Autonomic Neuropathies1
Lung Diseases1
Vascular Diseases1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.